Hall v. Annucci

CourtDistrict Court, S.D. New York
DecidedSeptember 24, 2021
Docket7:19-cv-05521
StatusUnknown

This text of Hall v. Annucci (Hall v. Annucci) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hall v. Annucci, (S.D.N.Y. 2021).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK RALPH HALL, Plaintiff, No. 19-CV-5521 (KMK) -v- OPINION & ORDER ANTHONY ANNUCCI, et al., Defendants.

Appearances: Ralph Hall Stormville, NY Pro se Plaintiff Brendan M. Horan, Esq. State of New York Office of the Attorney General New York, NY Counsel for Defendants KENNETH M. KARAS, District Judge: Pro se Plaintiff Ralph Hall (“Plaintiff”) brings the instant Action, pursuant to 42 U.S.C. § 1983, against Anthony Annucci (“Annucci”), Acting Commissioner of the New York State Department of Corrections and Community Supervision (“DOCCS”); Thomas Griffin (“Griffin”), Superintendent of Green Haven Correctional Facility (“Green Haven”); Dr. Robert Bentivegna (“Bentivegna”), “Medical Supervisor” at Green Haven; Dr. Kyoung Kim (“Kim”), “Medical Provider” at Green Haven; and Green Haven Nurses Aileen McCarthy (“McCarthy”), Donna Heitz (“Heitz”), Deborah MacDonald (“MacDonald”), and Nicole Walsh (“Walsh”) (collectively, “Defendants”). (Third Am. Compl. (“TAC”) 6–7 (Dkt. No. 81).) Before the Court is Defendants’ Motion To Dismiss, (see Not. of Mot. (Dkt. No. 103)), and Plaintiff’s putative Motion for an order to show cause, (see Not. of Mot. (Dkt. No. 125)). For the reasons discussed below, Defendants’ Motion and Plaintiff’s Motion are both denied. I. Background A. Factual Background 1. Allegations in Plaintiff’s Third Amended Complaint The pertinent facts, drawn from Plaintiff’s Third Amended Complaint (“TAC”) and taken as true for purposes of resolving the Motion To Dismiss, are as follows. From around September

26, 2017 through October 30, 2017, Plaintiff was confined at the Green Haven infirmary to recuperate and recover from an “invasive surgery” and replacement of his left hip to complete “bi-lateral hip replacement(s).” (TAC 8.)1 Plaintiff’s wound and dressing were not properly cleansed or sanitized, and, as a result, he contracted methicillin-resistant Staphylococcus aureus, commonly known as “MRSA.” (See id.) See also Ctrs. for Disease Control & Prevention (“CDC”), Methicillin-resistant Staphylococcus aureus (MRSA): General Information, https://www.cdc.gov/mrsa/community/index.html.2 Plaintiff was released from hospital “confinement” on October 30, 2017 and returned to the general prison population. (TAC 8–9.) Because his “wound was leaking,” however, Plaintiff “was forced to return to the hospital daily

in order to obtain band[-]aid[s].” (Id. at 9.) These bandages were Plaintiff’s “only change in

1 Quotations to Plaintiff’s submissions occasionally reflect minor corrections in grammar, punctuation, and spelling.

2 A court may take judicial notice of a fact “that is not subject to reasonable dispute because it . . . can be accurately and readily determined from sources whose accuracy cannot reasonably be questioned . . . at any stage in the proceeding,” including on a motion to dismiss. Dumel v. Westchester County, No. 19-CV-2161, 2021 WL 738365, at *1 n.5 (S.D.N.Y. Feb. 25, 2021) (alterations in original) (quoting Allianz Glob. Investors GmbH v. Bank of Am. Corp., 457 F. Supp. 3d 401, 410 n.3 (S.D.N.Y. 2020)). “Courts have taken judicial notice of facts from reputable medical sources such as the CDC in order to provide background information.” Id. (gathering cases). Although Plaintiff describes MRSA as an “incurable, flesh-eating” disease, (TAC 8), MRSA can, in fact, be treated and cured, see CDC, Methicillin-resistant Staphylococcus aureus (MRSA): For Patients, https://www.cdc.gov/mrsa/community/patients .html (stating that MRSA can be treated, and that “there are antibiotics that can kill MRSA germs”). dressing” from September 26, 2017 until his return to the general population on October 30, 2017. (Id.) On November 5, 2017, the “wound’s secretions were sent for laboratory testing,” the results of which indicated that Plaintiff “was potentially, and probably[,] infecting staff and prison population with an incurable infectious disease.” (Id.) Plaintiff was kept in “‘punitive’ isolation confinement,” where he was medicated and quarantined until his release around

November 13, 2017. (Id.) Plaintiff’s principal grievance is that Green Haven staff allegedly failed to clean and dress his wound properly during the roughly month-long period he spent in the prison infirmary, and that he did not receive appropriate care for the wound until after he contracted MRSA. (See id. at 14 (emphasizing that it was not until after Plaintiff contracted MRSA that a “separate nurse was assigned to cleanse and dress [his] wound daily and nightly”).) Plaintiff alleges that by contracting MRSA, he has suffered a “life-altering injur[y].” (Id.) Plaintiff purports to bring five causes of action against Defendants. (See id. at 10.) First, Plaintiff alleges that Defendants “show[ed] and demonstrate[d] indifference and an attitude of impunity” in “fail[ing] to act to mitigate [a] foreseeable risk of contracting [an] incurable

infectious disease.” (Id. at 11.) Second, Plaintiff alleges that Defendants Griffin and Bentivegna “condon[ed] unhygienic conditions under their watch. (Id. at 12.) Third, Plaintiff alleges that Defendant Kim “failed to reasonably supervise his nurses, resulting in an inexcusable failure to provide appropriate medical attention or treatment to protect the Plaintiff-patient from contracting a foreseeable . . . infection.” (Id. at 12–13.) Fourth, Plaintiff alleges that Defendants Kim and Bentivegna “share the responsibility for the health and wellbeing of the Plaintiff-patient under their care as healthcare professionals and agents under the DOCCS Commissioner governed by State Directives . . . 4300 and 2614.” (Id. at 13.) And fifth, Plaintiff alleges that Defendants McCarthy, Heitz, MacDonald, and Walsh “failed or refused to cleanse or change [the] dressing on [Plaintiff’s] open and leaking wound until it was determined that [he] had contracted [MRSA].” (Id. (underlining and quotation marks omitted).) Plaintiff requests a total of $100 million in damages for the five causes of action. (Id. at 15.) 2. Allegations in Plaintiff’s Putative Motion for Order to Show Cause In a putative Motion for an order to show cause filed on February 19, 2021, Plaintiff

alleged that, “for the last [four to five] months,” he had been “ordered to give blood samples no less than twice a month, . . . without first being administered antibiotic medication.” (Pl.’s Mot. for Order to Show Cause (“Pl.’s Mot.”) 5 (Dkt. No. 125).) In so doing, Plaintiff alleges, Defendants are “fail[ing] to observe the surgeon’s warning about causing bleeding without first administering antibiotics.” (Id. at 6.) He requests that Defendants be ordered to show cause as to why a “preliminary and/or permanent injunction should not issue against [them] for failing to observe the surgeon’s instruction and warning against any proceeding that would cause bleeding without first . . . administering antibiotics to prevent” a recurrence of MRSA. (Id. at 4.) Plaintiff’s putative Motion contains other allegations whose significance is not entirely

clear, except perhaps to provide context as to why Defendants were drawing Plaintiff’s blood. Specifically, Plaintiff was advised that his blood showed “irregularities” unrelated to MRSA, and, at some point, “Defendants . . . decided [that] Plaintiff [has] cancer in his prostate.” (Id.) Plaintiff was scheduled for cancer surgery at a hospital outside Green Haven. (Id.) As part of pre-surgical preparation, Plaintiff was administered Ciprofloxacin and Amoxicillin, “which served to provide relief” approximately 24 hours before he was scheduled to leave the prison for his surgery. (Id.) Plaintiff alleges that from January 29, 2021 through February 1, 2021, he “was kept in punitive isolation confinement . . .

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Booth v. Churner
532 U.S. 731 (Supreme Court, 2001)
Porter v. Nussle
534 U.S. 516 (Supreme Court, 2002)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Slayton v. American Express Co.
604 F.3d 758 (Second Circuit, 2010)
Cacchillo v. Insmed, Inc.
638 F.3d 401 (Second Circuit, 2011)
Williams v. Time Warner Inc.
440 F. App'x 7 (Second Circuit, 2011)
Ognibene v. Parkes
671 F.3d 174 (Second Circuit, 2011)
Koch v. Christie's International PLC
699 F.3d 141 (Second Circuit, 2012)
Kleinman v. Elan Corp., plc
706 F.3d 145 (Second Circuit, 2013)
Sykes v. Bank of America
723 F.3d 399 (Second Circuit, 2013)
ATSI Communications, Inc. v. Shaar Fund, Ltd.
493 F.3d 87 (Second Circuit, 2007)
Caidor v. Onondaga County
517 F.3d 601 (Second Circuit, 2008)
Davidson v. Scully
914 F. Supp. 1011 (S.D. New York, 1996)

Cite This Page — Counsel Stack

Bluebook (online)
Hall v. Annucci, Counsel Stack Legal Research, https://law.counselstack.com/opinion/hall-v-annucci-nysd-2021.